“High Percentages of Resistance to Tetracycline and Penicillin and Reduced Susceptibility to Azithromycin Characterize the Majority of Strain Types of.

Slides:



Advertisements
Similar presentations
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Advertisements

Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
Module 4: Final Case Study # 4-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 4-CS-2.
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
1. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus 2. Department of Clinical.
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
STD Surveillance 2001 Adapted from CDC by Jill Gallin, CPNP Assistant Professor of Clinical Nursing.
PHL 424 Antimicrobials 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
Gonococcal Isolate Surveillance Project (GISP)
Gonorrhea Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
Gonorrhea Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Gonorrhea Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Departmental Perspectives on Viral Hepatitis
National Medicine Policy
Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Steven.
IDSA / ISAP / FDA Workshop on Antimicrobial Drug Development Update 2004 Edward Cox, MD MPH ODE IV Center for Drug Evaluation and Research US Food and.
REGIONAL HEALTHCARE CENTER ASSOC. PROF. D-R PETKO SALCHEV PhD.
GETTING READY FOR DUAL EMTCT VALIDATION IN THE AMERICAS Adele Schwartz Benzaken.
Analysis of mutations within multiple genes associated with resistance in clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility.
Trevor Winstanley Rebecca Clarke Department of Microbiology
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
Antimicrobial Stewardship
Gonorrhea Epidemiology and Control Efforts in Louisiana Lisa Longfellow, MPH October 14, 2009.
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Rapid Emergence of Gonococcal Fluoroquinolone Resistance in Men Who Have Sex with Men in King County, WA WLH Whittington MR Golden KK Winterscheid SA Wang.
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
Ecoinformatics, Environmental Research: Current progress, research strategies and needs Ispra, Italy Jan 17 – 20, 2006 Environmental Public Health Indicators:
Sexually Transmitted Disease (STD) Surveillance Report, 2007 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Gonorrhea Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
The Genetics of Antibiotic Resistance Research Theme: Infectious Diseases Jason Kuehner March 5, 2007.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Unit 6: Specialised Techniques: Anti-Microbial Resistance Monitoring and Assessment of STI Syndrome Aetiologies #4-6-1.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
GONORRHEA Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Suttajit S a, Tantipidoke R a, Sitthi-amorn C a, Wagner A b, Ross-Degnan D b. a Chulalongkorn University, Bangkok; b Harvard Medical School, USA Problem.
Dr. Gamaliel Gutiérrez Regional Dengue Program PAHO/WHO WDC
Dutch antibiotic resistance policy
Gonorrhea Sexually Transmitted Disease Surveillance 2006 Division of STD Prevention.
22 February 2016 GRASP (Gonococcal Resistance to Antimicrobials Surveillance Programme) Catherine Ison Sexually Transmitted Bacteria Reference Laboratory.
Antimicrobial Resistance Surveillance (AMR Surveillance)
GONORRHEA Sexually Transmitted Disease Surveillance 2010 Division of STD Prevention.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Primary health care Dr. Hassan M. Alnuaimy Msc. Orthodontics.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
Antimicrobial susceptibility patterns of Polish invasive isolates of Neisseria meningitidis in the years Marcin Kadłubowski 1, Anna Skoczyńska.
Gonorrhea Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
Efficacy of gentamicin in combination with other different antimicrobials: optimism to treat and combat superbug Neisseria gonorrhoeae Vikram Singh 1,
HTM Seminar June 2015 Country Presentations CUBA Ing. Jorge Castro Medina Clinical Eng. Dep. Manager National Hospital for Physical.
Antimicrobial Stewardship
Department of Health Philippines Short Briefing.
Lizzi Torrone, MSPH, PhD Lead, Surveillance & Special Studies Team
Latin American Biologics/Biosimilars Conference
BULGARIA Istanbul, February, Turkey
Gonococcal Isolate Surveillance Project (GISP)
Sexually Transmitted Disease Surveillance 2009
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
Social Distancing Decision Making Protocol
Gonorrhea Epidemiology and Control Efforts in Louisiana
ANTIBIOTIC-RESISTANT GONORRHEA
Gonorrhea Sexually Transmitted Disease Surveillance 2010
مدیریت سندرومی بیماران آمیزشی مقدمه
A decade of multi-drug resistant N. gonorrhoea in Coventry, UK
Neisseria gonorrhoeae: the first untreatable infection
The Role of NICs in Influenza Surveillance
Gonorrhoea antimicrobial resistance in Ireland, 2010 – 2017 On behalf of the National Forum on Antimicrobial Resistance in Neisseria gonorrhoeae Health.
Volume 151, Issue 4, Pages (April 2017)
Antimicrobial resistance
Presentation transcript:

“High Percentages of Resistance to Tetracycline and Penicillin and Reduced Susceptibility to Azithromycin Characterize the Majority of Strain Types of Neisseria gonorrhoeae Isolates in Cuba, ” Sosa J, Ramirez-Arcos S, Ruben M, Li H, Llanes R, Llop A, Dillon JA (Sexually Transmitted Diseases 2003 May; 30(5):443-8.) Presentation: Jim Starman, MS-II Faculty Advisor: David Paterson, MD

Background Gonococcal disease is a significant problem within Latin American countries such as Cuba. Between 1960 and 1994, cases of gonorrhea reported in Cuba increased from 130 in 1960 to 34,224 in 1994 and 33,948 in During the last two decades, significant resistance has developed within N. gonorrhoeae strains worldwide to antibiotics such as azithromycin, penicillin, and tetracycline. The resistance profile of the gonococcal strains in a particular region should be considered when choosing a treatment in order to avoid using ineffective antibiotics.

GASP The Gonococcal Antimicrobial Surveillance Program (GASP) is an international initiative developed to characterize current patterns of resistance and to monitor developing new resistances of gonococcal strains in the Americas and Caribbean. GASP is based on the model of other microbial surveillance programs already in place as a result of the efforts of the Pan American Health Organization.

GASP The program’s goal is to provide accurate recommendations to physicians about the most effective choices of antibiotics for treatment of gonococcal infection in their region, based on the latest resistance patterns detected. Although Cuba has been a member since 1999, prior to this article, no study has fully characterized the patterns and types of antibiotic resistance within N. gonorrhoeae in the country.

Healthcare and Health Surveillance in Cuba: An Overview 11,273,000 total inhabitants (2002) The health system is structured in three levels that correspond to the political and administrative subdivisions of the country: national, provincial, and municipal.

Healthcare and Health Surveillance in Cuba: An Overview The national level is governed by the ministry of public health (MINSAP). MINSAP plays a steering role and carries out methodological, regulatory, coordination, and control functions. The municipal level consists of departments of public health that “are subject to the authority of municipal people's councils, polyclinics, and health areas.” 2 There are 145 local/municipal healthcare units, and 14 regional units across the country. These may be utilized as information gathering points for the GASP surveillance program. (11 of the 14 regional units served as sources for this study)

Map of Cuba

Health Surveillance in Cuba: The Problem Cuba’s attempts to monitor resistance patterns in strains of N. gonorrhoeae have been sporadic and limited due to economic constraints, resulting in a lack of up to date or even basic information about the distribution of resistant strains within the country. Without surveillance, Cuban healthcare workers lack the information to make intelligent decisions about which antibiotics to use when treating gonococcal infection. This leads to ineffective treatment, poor use of limited medical resources, and promotion of additional resistance development.

Study Objectives To collect and analyze strains of Neisseria gonorrhoeae from provincial healthcare centers across Cuba collected between 1995 and 1998, in order to assess the existing types and levels of resistance. To evaluate current treatment recommendations in each regional center and suggest changes where needed. To highlight the need for up to date surveillance of antibiotic resistance in N. gonorrhoeae and other microbes in Cuba and elsewhere.

Study Design 91 isolates were gathered from 11 of the 14 provincial health centers across Cuba between 1995 and 1998, and were sent to the Center for the Gonococcal Antimicrobial Surveillance Program in the Americas and the Caribbean, in Ottawa, for evaluation of resistance patterns.

Study Design Isolates were tested to find the minimum inhibitory concentrations (MIC) of the following antibiotics: Penicillin Tetracycline Spectinomycin Ceftriaxone Azithromycin Ciprofloxacin

Study Design MIC’s above a specific level for each antibiotic constitute “resistance” of a strain to that antibiotic. MIC’s above the normal MIC level but below the critical level for the definition of resistance constitute strains with decreased susceptibility to a given antibiotic.

Study Design All isolates were also analyzed for their auxotype, serotype, and pulse field gel electrophoresis characteristics. This was intended to identify the total number of distinct strains in the study, the individual resistance patterns of each strain, and finally, their distribution and prevalence in the country.

Results 68.1% of all isolates (62/91) were resistant to penicillin, of which most (52) were penicillinase producing N. gonorrhoeae. 83.5% of all isolates (76/91) were resistant to tetracycline. There were 45 isolates which had resistance to both penicillin and tetracycline (49.4%).

Results 9.9% (9/91) of isolates were resistant to azithromycin. In addition, 47.3% (43/91) of isolates showed decreased susceptibility (an elevated MIC). All isolates were susceptible to spectinomycin, ceftriaxone, and ciprofloxacin.

Results: A/S and PFGE Auxotype/Serotype Class Total Number of Isolates Number of Sub- Classes Major Antibiotic resistance types NR/IA-6358 Plasmids conferring penicillin and tetracycline resistance: (32/35) P/IA-6113 Chromosome-mediated penicillin and tetracycline resistance: (5/11) Plasmids conferring resistance to tetracycline: (8/11) NR/IB-1156 Reduced azithromycin susceptibility: (15/15)

Discussion Almost all isolates had resistance or decreased susceptibility to Penicillin, reflecting the previously reported resistances in other Latin American countries. In addition, all isolates had at least reduced levels of susceptibility to tetracycline. Most of the developed resistance patterns are plasmid mediated.

Discussion Resistance is more common today than in the late 1980s and early 1990s, and new forms continue to emerge. Cuba has already developed strains that are resistant to the two cheapest antibiotics, Penicillin and Tetracycline, and is likely to face resistance to more expensive drugs as well in the near future.

Discussion There were 4 recent cases from one Cuban town in which reduced susceptibility to ciprofloxacin was reported, and in other parts of the world such as the Asian-Pacific region, ciprofloxacin resistance has been reported in as many as 30% of isolates. Therefore, although no ciprofloxacin resistance was detected in the current Cuban study, it is likely to increase in the near future.

Discussion It is crucial to continue to develop and maintain adequate surveillance networks through the GASP program in order to maintain effective treatment strategies. Antibiotic recommendations for current use should more closely reflect the data collected by the present study of resistance patterns. (This is an important point, since it is likely that the updated information is not currently distributed in an effective manner to those who may utilize it)

Discussion Information about the geographic distribution of resistant strains may be useful for a public health strategy aimed at disease prevention. Some other important related issues to consider: 1)Compliance to prescribed therapies. 2)Quality of medications/ adequate supply.

References 1)Minesterio de salud Publica de Cuba. Programma national de control de las ITS in Cuba. Minesteria de salud Publica, Cuidad de la Habana ) Pan American Health Organization ( 3) World Health Organization (

Thank You!